Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

BiondVax Pharmaceuticals Ltd. BVXV NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

SharesGrow Score
42/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — BVXV

BiondVax Pharmaceuticals Ltd. (BVXV) has a market capitalization of $4.97M and trades at $1.36. The 52-week range is 0.63-11.49.

The stock has a beta of 2.37, operates in the Healthcare sector.

Trading Data
Current Price$1.36
52-Week Range0.63-11.49
Volume22.67K
Avg Volume (30D)38.94K
Market Cap$4.97M
Beta (1Y)2.37
Company
IPO Date2015-05-12
Employees33
CEOAmir Reichman
CountryIL
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS09073Q1058
CUSIP09073Q105
Income (Latest Year)
EBITDA$-10.5M
Operating Income$-11.06M
Net Income$-531K
Shares Outstanding$754.08B
Balance Sheet (Latest Year)
Total Assets$27.07M
Current Assets$14.37M
Cash & ST Investments$14.08M
Total Liabilities$28.83M
Total Debt$21.54M
Net Debt$7.47M
Total Equity$-1.76M
Debt / Equity-12.24
Valuation Ratios

People Also View

MLYS
MLYS
Mineralys Therapeutics, Inc.
$30.42
+11.35%
 PHVS
PHVS
Pharvaris N.V.
$29.14
+1.60%
 ARMP
ARMP
Armata Pharmaceuticals, Inc.
$12.06
-6.37%
 SRZN
SRZN
Surrozen, Inc.
$32.02
+0.53%
 MDWD
MDWD
MediWound Ltd.
$17.25
-2.54%
 MOLN
MOLN
Molecular Partners AG
$4.20
+1.45%
 ORMP
ORMP
Oramed Pharmaceuticals Inc.
$3.82
+0.53%
 PEPG
PEPG
PepGen Inc.
$1.72
+1.78%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message